No interaction between the APOE and the alpha-1-antichymotrypsin genes on risk for Alzheimer's disease

This publication has 11 references indexed in Scilit:

• Apolipoprotein E genotyping in Alzheimer's disease
  The Lancet, 1996
• Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease
  Nature Genetics, 1995
• A4POE*4-associated Alzheimer's disease risk is modified by α1–antichymotrypsin polymorphism
  Nature Genetics, 1995
• Evidence that the APOE locus influences rate of disease progression in late onset familial Alzheimer's Disease but is not causative
  American Journal of Medical Genetics, 1995
• Acute Phase Reactant α1Antichymotrypsin Is Increased in Cerebrospinal Fluid and Serum of Patients with Probable Alzheimer Disease
  Alzheimer Disease & Associated Disorders, 1995
• Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments
  Nature, 1994
• Apolipoprotein E, ɛ4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region
  Human Molecular Genetics, 1994
• Apolipoprotein E polymorphism and Alzheimer's disease
  The Lancet, 1993
• ?₁-Antichymotrypsin Binding to Alzheimer A? Peptides Is Sequence Specific and Induces Fibril Disaggregation In Vitro
  Journal of Neurochemistry, 1993
• Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
  Proceedings of the National Academy of Sciences, 1993